These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 3938936)
41. Evidence for a long-term effect of a single dose of praziquantel on Schistosoma mansoni-induced hepatosplenic lesions in northern Uganda. Frenzel K; Grigull L; Odongo-Aginya E; Ndugwa CM; Loroni-Lakwo T; Schweigmann U; Vester U; Spannbrucker N; Doehring E Am J Trop Med Hyg; 1999 Jun; 60(6):927-31. PubMed ID: 10403322 [TBL] [Abstract][Full Text] [Related]
42. Praziquantel in the treatment of Schistosoma mansoni infection: comparison of 40 and 60 mg/kg bodyweight regimens. Abu-Elyazeed RR; Youssef FG; Merrell BR; El-Gamal RL; El-Khoby TA; Hassanein YA; Cummings CE Am J Trop Med Hyg; 1997 Apr; 56(4):404-7. PubMed ID: 9158048 [TBL] [Abstract][Full Text] [Related]
43. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Stelma FF; Talla I; Sow S; Kongs A; Niang M; Polman K; Deelder AM; Gryseels B Am J Trop Med Hyg; 1995 Aug; 53(2):167-70. PubMed ID: 7677219 [TBL] [Abstract][Full Text] [Related]
44. Schistosoma mansoni eggs as a target for praziquantel: efficacy of oral application in mice. Giboda M; Smith JM J Trop Med Hyg; 1994 Apr; 97(2):98-102. PubMed ID: 8170010 [TBL] [Abstract][Full Text] [Related]
45. Efficacy of myrrh in the treatment of human Schistosomiasis mansoni. Barakat R; Elmorshedy H; Fenwick A Am J Trop Med Hyg; 2005 Aug; 73(2):365-7. PubMed ID: 16103605 [TBL] [Abstract][Full Text] [Related]
47. Epidemiological studies on Schistosoma mansoni infection in the western region of Saudi Arabia using the potassium hydroxide stool digestion technique. Ghandour AM; al-Robai AA; Doenhoff M; Banaja AA J Trop Med Hyg; 1995 Feb; 98(1):57-63. PubMed ID: 7861481 [TBL] [Abstract][Full Text] [Related]
48. Immuno-epidemiology of Schistosoma mansoni infections in a recently exposed community in Senegal. Gryseels B; Stelma F; Talla I; Polman K; Van Dam G; Sow S; Diaw M; Sturrock RF; Decam C; Niang M Mem Inst Oswaldo Cruz; 1995; 90(2):271-6. PubMed ID: 8531670 [TBL] [Abstract][Full Text] [Related]
49. Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity twenty-three months after treatment with praziquantel. Doehring-Schwerdtfeger E; Abdel-Rahim IM; Kardorff R; Kaiser C; Franke D; Schlake J; Richter J; Elsheikh M; Mohamed-Ali Q; Ehrich JH Am J Trop Med Hyg; 1992 Apr; 46(4):409-15. PubMed ID: 1575287 [TBL] [Abstract][Full Text] [Related]
50. Reduction in prevalence, intensity of infection and morbidity due to Schistosoma mansoni infection in a community following treatment with praziquantel. Sukwa TY; Bulsara MK; Wurapa FK J Trop Med Hyg; 1987 Aug; 90(4):205-11. PubMed ID: 3116277 [TBL] [Abstract][Full Text] [Related]
51. Field trials of praziquantel and oxamniquine for the treatment of schistosomiasis mansoni in Burundi. Gryseels B; Nkulikyinka L; Coosemans MH Trans R Soc Trop Med Hyg; 1987; 81(4):641-4. PubMed ID: 3127965 [TBL] [Abstract][Full Text] [Related]
52. Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt. Barakat R; El Morshedy H Parasitology; 2011 Apr; 138(4):440-6. PubMed ID: 21078223 [TBL] [Abstract][Full Text] [Related]
53. Praziquantel efficacy against schistosomiasis mansoni in schoolchildren in north-west Ethiopia. Degu G; Mengistu G; Jones J Trans R Soc Trop Med Hyg; 2002; 96(4):444-5. PubMed ID: 12497985 [TBL] [Abstract][Full Text] [Related]
54. Parenteral antischistosomal therapy: a potential risk factor for hepatitis B infection. Hyams KC; Mansour MM; Massoud A; Dunn MA J Med Virol; 1987 Oct; 23(2):109-14. PubMed ID: 3119770 [TBL] [Abstract][Full Text] [Related]
55. Patients with severe schistosomiasis mansoni in Ituri Province, Democratic Republic of the Congo. Nigo MM; Odermatt P; Nigo DW; Salieb-Beugelaar GB; Battegay M; Hunziker PR Infect Dis Poverty; 2021 Mar; 10(1):39. PubMed ID: 33762007 [TBL] [Abstract][Full Text] [Related]
56. Efficacy of Myrrh in the treatment of schistosomiasis (haematobium and mansoni) in Ezbet El-Bakly, Tamyia Center, El-Fayoum Governorate, Egypt. Abo-Madyan AA; Morsy TA; Motawea SM J Egypt Soc Parasitol; 2004 Aug; 34(2):423-46. PubMed ID: 15287168 [TBL] [Abstract][Full Text] [Related]
57. A case of bowel schistosomiasis not adhering to endoscopic findings. Rizzo M; Mansueto P; Cabibi D; Barresi E; Berneis K; Affronti M; Di Lorenzo G; Vigneri S; Rini GB World J Gastroenterol; 2005 Nov; 11(44):7044-7. PubMed ID: 16437615 [TBL] [Abstract][Full Text] [Related]
58. Praziquantel and oltipraz: the treatment of schoolchildren infected with Schistosoma mansoni and/or Schistosoma haematobium in Gezira, Sudan. el Tayeb M; Daffalla AA; Kardaman MW; See R; Fenwick A Ann Trop Med Parasitol; 1988 Feb; 82(1):53-7. PubMed ID: 3135786 [TBL] [Abstract][Full Text] [Related]
59. Effectiveness of praziquantel against the South African strains of Schistosoma haematobium and S. mansoni. Schutte CH; Osman Y; Van Deventer JM; Mosese G S Afr Med J; 1983 Jul; 64(1):7-10. PubMed ID: 6344270 [TBL] [Abstract][Full Text] [Related]
60. Circulating schistosomal antigen in diagnosis and assessment of cure in individuals infected with Schistosoma mansoni. Hassan MM; Badawi MA; Strand M Am J Trop Med Hyg; 1992 Jun; 46(6):737-44. PubMed ID: 1621899 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]